Table 1 |
|||||||
|
A summary of loci associated with systemic lupus erythematosus in one or more genome-wide association studies, a meta-analysis, and replication studies (P <1 |
|||||||
|
Locus |
Gene |
Position |
Variant |
P value (significance) |
OR (CI) effect(size) |
Autoimmune disease association |
Function |
|
|
|||||||
|
ITGAMa |
Intergrin alpha M |
16p11.2 (intronic) |
rs9888739 (T) |
1.61×10-23 |
1.62 (1.47-1.78) |
Phagocytosis |
|
|
FcγR |
Fcγ receptors |
Multiple(see text) |
Multiple (see text) |
Multiple (see text) |
Multiple (see text) |
UC |
Phagocytosis |
|
PRDM1-ATG5b |
PR domain zinc finger protein 1-autophagy-related 5 homolog |
6q21-q22.1 (intergenic) |
rs548234 (G) |
5.18×10-12 |
1.25 (1.17-1.33) |
Autophagy and B-cell differentiation |
|
|
TNFAIP3b |
Tumor necrosis factor-alpha-induced protein |
6q23 (exonic) |
rs2230926 (C) |
1.37×10-17 |
1.72 (1.52-1.94) |
RA, CeID, UC, and PS |
Ubiquitination |
|
TNIP1e |
TNFAIP3-interacting protein 1 |
5q32-q33.1 (intronic) |
rs7708392 (C) |
3.8×10-13 |
1.27 (1.10-1.35) |
PS |
|
|
UBE2L3b |
Ubiquitin-conjugating enzyme E2L 3 |
22q11.2- q13.1 (upstream) |
rs463426 (G) |
1.48×10-16 |
0.78 (0.74-0.83) |
CD, RA, and CeID |
|
|
ETS1b |
V-ETS avian erythroblastosis virus E26 oncogene homolog 1 |
11q23.3 (downstream) |
rs6590330 (A) |
1.77×10-25 |
1.37 (1.29-1.45) |
RA |
Lymphocyte development and activation |
|
IKZF1b |
IKAROS family zinc finger 1 |
7p12 (upstream) |
rs4917014 (C) |
2.75×10-23 |
1.23 (1.03-1.42) |
||
|
CD44d |
CD44 |
11p13 (upstream) |
rs507230 |
3.98×10-12 |
0.71 (0.63-0.79) |
||
|
BANK1c |
B-cell sca3 old protein with ankyrin repeats 1 |
4q22-q24 (exonic) |
rs10516487 (G) |
3.7×10-10 |
1.38 (1.25-1.53) |
RA |
B-cell activation and signaling |
|
BLKb |
B lymphoid tyrosine kinase |
8p23-p22 (upstream) |
rs7812879 (A) |
2.09×10-24 |
0.69 (0.64-0.74) |
RA |
|
|
LYNa |
V-yes-1 Yamaguchi sarcoma viral-related oncogene homolog |
8q13 (intronic) |
rs7829816 (C) |
5.40×10-9 |
0.77 (0.70-0.84) |
||
|
RasGRP3b |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
2p25.1-p24.1 (intronic) |
rs13385731 (G) |
1.25×10-15 |
0.70 (0.64-0.76) |
||
|
NCF2f |
Neutrophil cytosolic factor 2 |
1q25(intronic) |
rs10911363 (T) |
2.87×10-11 |
1.18 (1.10-1.30) |
||
|
STAT4b |
Signal transducer and activator of transcription 4 |
2q32.2-q 32.3 (intronic) |
rs7574865 (A) |
5.17×10-42 |
1.51 (1.43-1.61) |
RA, IBD, T1D, and Sjögren's syndrome |
T-cell development and signaling |
|
PTPN22e |
Protein tyrosine phosphatase non-receptor type 22 |
1p13 (exonic) |
rs2476601 (A) |
3.4×10-12 |
1.35 (1.24-1.47) |
T1D and Graves' disease |
|
|
TNFSF4b |
Tumor necrosis factor (ligand) superfamily member 4 |
1q25 (upstream) |
rs2205960 (A) |
2.5×10-32 |
1.46 (1.37-1.56) |
||
|
HLA-DRB1e |
HLA class II histocompatibility antigen |
6p21.3(downstream) |
rs3135394 (G) |
2.0×10-60 |
1.98 (1.84-2.14) |
T1D, RA, CeID, IBD, and CD |
Antigen presentation |
|
SLC15A4b |
Solute carrier family 15, member 4 |
12q24.32 (exonic) |
rs10847697 (A) |
3.54×10-11 |
1.26 (1.17-1.34) |
||
|
IRF5e |
Interferon regulatory factor 5 |
7q32(3' untranslated region) |
rs2070197 (C) |
5.8×10-24 |
1.88 (1.78-1.95) |
Rheumatic disease and RA |
Interferon regulation and production |
|
IRF7a |
Interferon regulatory factor 7 |
11p15.5(downstream) |
rs4963128 (T) |
3.0×10-10 |
0.78 (0.73-0.85) |
T1D |
|
|
IRF8f |
Interferon regulatory factor 8 |
16q24.1 (downstream) |
rs2280381 (A) |
1.24×10-8 |
1.17 (1.10-1.24) |
UC and MS |
|
|
IFIH1f |
Interferon-induced helicase C domain- containing protein 1 |
2q24 (exonic) |
rs1990760 (T) |
1.63×10-8 |
1.23 (1.09-1.39) |
||
|
TYK2f |
Tyrosine kinase 2 |
19p13.2(intronic) |
rs280519 (A) |
3.88×10-8 |
1.29 (1.15-1.47) |
MS |
|
|
LRRC18- |
Leucine-rich repeat |
10q11.22-q11.23 |
rs1913517 (A) |
7.22×10-12 |
1.24 (1.17-1.32) |
Unknown function |
|
|
WDFY4b |
containing 18-WD repeat and FYVE domain-containing protein 4 |
(intergenic) |
|||||
|
PXKa |
PX domain containing serine/threonine kinase |
3p14.3(intronic) |
rs6445975 (C) |
7.10×10-9 |
1.25 (1.16-1.35) |
RA |
|
|
JAZF1e |
Juxtaposed withanother zinc finger gene 1 |
7p15 (intronic) |
rs849142 (T) |
1.5×10-9 |
1.19 (1.13-1.26) |
||
|
UHRF1BP1e |
UHRF-binding protein 1 |
6q23(exonic) |
rs11755393 (G) |
2.2×10-8 |
1.17 (1.10-1.24) |
||
|
XKR6a |
XK, Kell blood group complex subunit- related family, member36 |
8p23.1(intronic) |
rs6985109 (G) |
2.51×10-11 |
1.23 (1.16-1.30) |
||
|
|
|||||||
|
Odds ratios (ORs) and confidence intervals (CIs) are noted with the primary function of each locus. The genome-wide association studies from which this table was generated were conducted by aHarley and colleagues [95] (1,846 systemic lupus erythematosus (SLE) women cases and 1,825 controls), bHan and colleagues [53] (1,047 Han Chinese cases and 1,205 controls), and cKozyrev and colleagues [59] (279 Swedish SLE cases and 515 controls). The meta-analysis study was conducted by dRamos and colleagues [58] (939 Caucasian cases and 3,398 controls). The replication studies were conducted by Han and colleagues [53] (3,152 Han Chinese cases and 7,050 controls), eGateva and colleagues [6] (1,963 cases and 4,329 controls), and fCunninghame Graham and colleagues [69] (870 UK SLE cases and 5,551 controls). All loci that have been reported to be associated with other autoimmune diseases - Crohn's disease (CD), celiac disease (CeID), irritable bowel syndrome (IBD), multiple sclerosis (MS), psoriasis (PS), rheumatoid arthritis (RA), type 1 diabetes (T1D), and ulcerative colitis (UC) - are also stated [58]. |
|||||||
|
Guerra et al. Arthritis Research & Therapy 2012 14:211 doi:10.1186/ar3844 |
|||||||